A role of aurora A tyrosine kinase inhibitor, Alisertib, in the resistance of cancer cells to Daunorubicin

被引：0
|
作者：
Yati, S. [1 ]
Novotna, E. [1 ]
Wsol, V. [1 ]
机构：
[1] Charles Univ Prague, Dept Biochem Sci, Hradec Kralove, Czech Republic
来源：
TOXICOLOGY LETTERS | 2024年 / 399卷
关键词：
D O I：
10.1016/j.toxlet.2024.07.905
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
LP-42
引用
收藏
页码：S380 / S381
页数：2
相关论文
共 50 条
  • [21] Effect of alisertib, an investigational aurora a kinase inhibitor on the QTc interval in patients with advanced malignancies
    Zhou, Xiaofei
    Nemunaitis, John
    Pant, Shubham
    Bauer, Todd M.
    Patel, Manish
    Sarantopoulos, John
    Lockhart, A. Craig
    Goodman, Daniel
    Huebner, Dirk
    Mould, Diane R.
    Venkatakrishnan, Karthik
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (02) : 240 - 247
  • [22] Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant CML cells
    Okabe, Seiichi
    Moriyama, Mitsuru
    Gotoh, Akihiko
    MEDICAL ONCOLOGY, 2024, 41 (06)
  • [23] Phase I study of the aurora kinase A inhibitor alisertib in combination with osimertinib in EGFR-mutant lung cancer.
    Blakely, Collin M.
    Gubens, Matthew A.
    Allen, Gregory M.
    Shah, Shrusti
    Jereza, Matthew
    Bacaltos, Bianca
    Bandyopadhyay, Sourav
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] MLN8237 (alisertib), an investigational Aurora A Kinase inhibitor, in patients with breast cancer: Emerging phase 2 results
    Alvarez, R. H.
    DeMichele, A.
    Mailliez, A.
    Benaim, E.
    Fingert, H.
    Schusterbauer, C.
    Zhang, B.
    Melichar, B.
    CANCER RESEARCH, 2012, 72
  • [25] Targeting aurora kinase b overcomes acquired resistance to met-tyrosine kinase inhibitor in met-amplified lung cancer
    Choi, Yura
    Hwang, Mihwa
    Kim, Sunshin
    Song, Jae J.
    Lee, Youngjoo
    CANCER RESEARCH, 2023, 83 (07)
  • [26] The Role of Aurora B Kinase in Normal and Cancer Cells
    Ekaterina Titova
    Galina Shagieva
    Vera Dugina
    Pavel Kopnin
    Biochemistry (Moscow), 2023, 88 : 2054 - 2062
  • [27] The Role of Aurora B Kinase in Normal and Cancer Cells
    Titova, Ekaterina
    Shagieva, Galina
    Dugina, Vera
    Kopnin, Pavel
    BIOCHEMISTRY-MOSCOW, 2023, 88 (12-13) : 2054 - 2062
  • [28] The role of histone lysine demethylases in cancer cells' resistance to tyrosine kinase inhibitors
    White, Jasmine Cassar
    Pucci, Perla
    Crea, Francesco
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 326 - 334
  • [29] Phase I study combining the aurora kinase A (AURKA) inhibitor alisertib (Ali) with mFOLFOX in gastrointestinal (GI) cancer.
    Goff, Laura Williams
    Azad, Nilofer Saba
    Stein, Stacey
    Whisenant, Jennifer
    Vaishampayan, Ulka N.
    Hochster, Howard S.
    Connolly, Raisin M.
    Weise, Amy M.
    LoRusso, Patricia
    El-Rifai, Wael
    Berlin, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Pharmacogenomics of Tyrosine Kinase Inhibitor Resistance
    Cascorbi, I.
    PUBLIC HEALTH GENOMICS, 2016, 19 : 2 - 2
12345